Title : Pharmacogenetics of irinotecan metabolism and transport: an update.

Pub. Date : 2006 Mar

PMID : 16271446






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Irinotecan is subject to extensive metabolism by various polymorphic enzymes, including CES2 to form SN-38, members of the UGT1A subfamily, and CYP3A4 and CYP3A5, which form several pharmacologically inactive oxidation products. Irinotecan carboxylesterase 2 Homo sapiens
2 Irinotecan is subject to extensive metabolism by various polymorphic enzymes, including CES2 to form SN-38, members of the UGT1A subfamily, and CYP3A4 and CYP3A5, which form several pharmacologically inactive oxidation products. Irinotecan carboxylesterase 2 Homo sapiens